These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 298944)

  • 1. [Geographical pathology and genetic markers: detection of associations (author's transl)].
    Feingold N
    Rev Epidemiol Sante Publique; 1979; 27(5-6):381-8. PubMed ID: 298944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic markers and disease susceptibility (author's transl)].
    Dausset J; Degos L
    Rev Epidemiol Sante Publique; 1979; 27(5-6):369-79. PubMed ID: 298943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histocompatibility HLA system in man. Considerations in the light of current concept. Part III. The relationship between HLA antigens and disease susceptibility].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(7-8):814-7. PubMed ID: 11769393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.
    Gorus FK
    Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The HLA system antigens in patients with cardiovascular diseases].
    Khaitov RM; Polianskaia IS; Alekseev LP
    Ter Arkh; 1990; 62(8):70-4. PubMed ID: 2274876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis.
    Cook AD; Stockman A; Brand CA; Tait BD; Mackay IR; Muirden KD; Bernard CC; Rowley MJ
    Arthritis Rheum; 1999 Dec; 42(12):2569-76. PubMed ID: 10616002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA and sprue: a study of Sicilian families with celiac disease].
    Cataldo F; Caruso C; Maltese I; Lio D; Marino V; Albeggiani A
    Pediatr Med Chir; 1990; 12(4):343-6. PubMed ID: 2075098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetic markers in hemoblastosis].
    Zaretskaia IuM; Khamaganova EG; Aleshchenko SM; Pivnik AV
    Ter Arkh; 2000; 72(12):54-7. PubMed ID: 11201835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to multiple sclerosis as revealed by immunoprinting.
    Epplen C; Jäckel S; Santos EJ; D'Souza M; Poehlau D; Dotzauer B; Sindern E; Haupts M; Rüde KP; Weber F; Stöver J; Poser S; Gehler W; Malin JP; Przuntek H; Epplen JT
    Ann Neurol; 1997 Mar; 41(3):341-52. PubMed ID: 9066355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
    Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
    Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic factors in the etiology of breast cancer (author's transl)].
    Sancho-Garnier H; Henry-Amar M; Lê M
    Bull Cancer; 1978; 65(2):127-30. PubMed ID: 359069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between case-control studies and the transmission/disequilibrium test.
    Mitchell LE
    Genet Epidemiol; 2000 Oct; 19(3):193-201. PubMed ID: 11015123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic epidemiology as a tool for investigating rheumatic disease.
    Ward RH
    J Rheumatol Suppl; 1983 Nov; 10():46-9. PubMed ID: 6420567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region.
    Kawabata Y; Ikegami H; Fujisawa T; Noso S; Asano K; Hiromine Y; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():278-84. PubMed ID: 17130566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Markers of genetic susceptibility to malignant neoplasms].
    Polzik EV; Katsnel'son BA; Iakusheva MI; Lezhnin VL; Kazantsev VS
    Vopr Onkol; 1993; 39(1-3):32-9. PubMed ID: 8073673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usual statistical methods for studying HLA-disease associations and linkages].
    Busson M; Prévost P
    Pathol Biol (Paris); 1986 Jun; 34(6):711-4. PubMed ID: 3531986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenetic studies on etiology of liver diseases - with HLA (human leucocyte antigen) as a genetic marker- (author's transl)].
    Shingami T
    Igaku Kenkyu; 1980 Apr; 50(3):216-41. PubMed ID: 6795890
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA system affects the age-at-onset in chronic myeloid leukemia.
    Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
    Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA in Buerger's disease.
    Numano F; Sasazuki T; Koyama T; Shimokado K; Takeda Y; Nishimura Y; Mutoh M
    Exp Clin Immunogenet; 1986; 3(4):195-200. PubMed ID: 3274054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma and HLA system.
    Perichon B; Krishnamoorthy R
    Allerg Immunol (Paris); 1991 Sep; 23(7):301-7. PubMed ID: 1741930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.